التفاصيل البيبلوغرافية
| العنوان: |
Acute exposure to hydrazine reported to four United States regional poison centers: reconsidering a paradigm. |
| المؤلفون: |
Nguyen, HoanVu N.1,2 (AUTHOR) hnnguy@ucdavis.edu, McElyea, Charles W. E.2 (AUTHOR), Chenoweth, James A.2 (AUTHOR), Nowadly, Craig D.3 (AUTHOR), Varney, Shawn M.4 (AUTHOR), Wilson, Bryan Z.5 (AUTHOR), Hoyte, Christopher O.6 (AUTHOR) |
| المصدر: |
Clinical Toxicology (15563650). May2024, Vol. 62 Issue 5, p322-328. 7p. |
| مصطلحات موضوعية: |
*POISON control centers, *HYDRAZINES, *HEALTH facilities, *OXYGEN therapy, *METHYL hydrazine, *VENOM |
| مصطلحات جغرافية: |
UNITED States |
| مستخلص: |
Exposures to hydrazines occur during aeronautic and space operations and pose a potential risk to personnel. Historically, extensive preparatory countermeasures have been taken due to concern for severe toxicity. This study seeks to better understand manifestations of acute occupational exposures to hydrazine to guide recommendations for management. A retrospective database review of records from four United States regional poison centers was conducted of all human exposures to hydrazine, monomethylhydrazine, or 1,1-dimethylhydrazine over two decades. Following case abstraction, descriptive statistics were performed to characterize demographics, manifestations, treatments, and outcomes. One hundred and thirty-five cases were identified, and most were adult males exposed to inhaled hydrazine propellant vapors. Fifty-seven percent of patients were asymptomatic following exposure; otherwise, common symptoms were dyspnea, throat irritation, cough, ocular irritation, and headache. All patients were evacuated or received decontamination, with a few reports of symptomatic treatments, including oxygen supplementation and salbutamol (albuterol). Patients usually recovered quickly and were released after a brief healthcare facility evaluation or observed locally. No patients developed delayed symptoms. Symptoms of severe toxicity were not observed, and there were no deaths. Acute exposures to hydrazines during operations within the aerospace industry appear to be limited primarily to mucosal and mild pulmonary irritation without significant neurologic, hepatic, or hematologic toxicity. These findings are contrary to previously established expectations and may be related to low-level exposures or possibly due to current emergency countermeasures. Care in occupational hydrazine exposure will focus on evacuation, decontamination, and symptomatic management of chemical irritant properties of hydrazines. It is reasonable to manage mild cases outside of a healthcare facility. Continued endeavors in human space exploration and habitation will increase the risk of these exposures, making it imperative that clinicians be comfortable with the care and management of these patients. [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: |
Academic Search Index |
